BTAIInvestor Event•globenewswire•August 13, 2025 at 11:00 AM

BioXcel Therapeutics to Participate in the H.C. Wainwright & Co. “HCW@Home” Series

Sentiment:Negative (20)

Summary

NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that Vimal Mehta, Ph.D., CEO of BioXcel Therapeutics, will participate in a virtual fireside chat on Thursday, August 14, 2025 at 1:00 p.m. ET as part of the H.C. Wainwright & Co. “HCW@Home” series.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 13, 2025 by globenewswire